The association of ibuprofen administration with higher acute kidney injury (AKI) and kidney replacement therapy in hospitalized patients was concentrated ...
The U.S. Food and Drug Administration (FDA) issued a Not Approvable Letter for Optune Mya for adult patients with brain ...
In Amgen-reported phase 3 results, dazodalibep reduced systemic disease activity versus placebo in patients with Sjögren's disease.
Compared with thoracic epidural, paravertebral blockade did not reduce chronic post-thoracotomy pain after 6 months.
Among a cohort of Chinese adults starting urate-lowering therapy, use of colchicine was not associated with a reduction in ...
A Phase 1 single ascending dose component of a randomized, double blind, placebo controlled trial, showed that ARO-DIMER-PA ...
In this cross-sectional study, health care providers (HCPs) identifying as a sexual minority reported more lifetime depression diagnoses and ...
Asundexian reduced ischemic stroke risk by 26% versus placebo in adults receiving antiplatelet therapy after recent ...
The Centers for Disease Control and Prevention (CDC) reported 5,182 confirmed measles cases in the United States as of ...
All rights reserved. No part of this article may be reproduced, distributed or transmitted in any form or by any means ...
The Food and Drug Administration (FDA) lists potential safety risks for compounded growth hormone releasing peptide-2 (GHRP-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results